Identifying Tumor Markers to Diagnose Mesothelioma
MESOMARK is a manual enzyme-linked immunosorbent assay or “ELISA”
which identifies tumor markers in the bloodstream. These tumor markers,
referred to as SMRPs or soluble mesothelin-related peptides, are released by
malignant mesothelioma cells. So MESOMARK searches a patient’s bloodstream to see if it
can find any markers that could indicate the presence of mesothelioma cancer.
It is the first blood test designed exclusively to monitor mesothelioma.
In 2007, Fujirebio Diagnostics developed the first in vitro test to measure
mesothelin for the monitoring of mesothelioma. This development offered
a new hope for thousands of Americans suffering from mesothelioma as well
as those who will eventually be diagnosed. This test was the first and
only mesothelioma monitoring system to measure proteins in a person’s
bloodstream as a way to reflect shifts in
In what cases do doctors use the MESOMARK test?
Doctors perform MESOMARK tests in order to measure the level of mesothelioma
markers in a person. This blood test helps determine if a person has mesothelioma
cancer as well as evaluate a patient’s response to various mesothelioma
What does the MESOMARK test entail?
If your doctor recommends the MESOMARK test, you can expect a small blood
sample. Your blood sample will be sent to a lab for additional testing
Were you or a loved one recently diagnosed with mesothelioma? We invite
you to contact Worthington & Caron, PC We have connections to some
of the nation’s top mesothelioma physicians and can help you with